Keyword Search
Legend:
CC = Baltimore Convention Center, H = Hilton Baltimore
* = applied session ! = JSM meeting theme
|
Keyword Search Criteria: Risk assessment returned 10 record(s)
|
|
Monday, 07/31/2017
|
What Role Should Statistics and Statisticians Play in Environmental Policy and Regulation?
Lara P. Phelps, U.S. Environmental Protection Agency, Office of the Science Advisor; James V. Zidek, Department of Statistics, University of British Columbia; Paul Black, Neptune & Company, Inc.; Steven P. Millard, Probability, Statistics, & Information; Kirk Cameron, MacStat Consulting, Ltd.; Veronica J Berrocal, University of Michigan
2:05 PM
|
|
Wednesday, 08/02/2017
|
The Prostate Biopsy Collaborative Group
Katharina Selig, Technical University of Munich; Johanna Straubinger, Technical University of Munich; Donna Ankerst , Technical University of Munich
|
On a Stepwise Quantitative Approach for Benefit-Risk Assessment
Weili He, Merck & Co., Inc.; Yaxuan Sun, Department of Statistics, Iowa State University, Ames, IA, USA; Qing Li, Merck & Co., Inc.; Sabrina Wan, Merck & Co., Inc.
2:05 PM
|
DMCS and Benefit:Risk Assessment
Scott Evans, Harvard University ; Christy Chuang-Stein, Retired!; Dave DeMets, Retired; Paul Gallo, Novartis; Weili He, Merck & Co., Inc.; Qi Jiang, Amgen Inc.; Frank Rockhold, Retired
2:25 PM
|
Using Patient Preference Information in Benefit-Risk Assessment
Xuefeng Li, FDA; George Quartey , Genetech
2:45 PM
|
Rationale for the Use of Subject Level Information for Benefit-Risk Evaluations
Shihua Wen, Novartis; Weili He, Merck & Co., Inc.; Scott Evans, Harvard University ; Qi Jiang, Amgen Inc.; Jonathan Norton, Takeda; Xuefeng Li, FDA; George Quartey , Genetech
3:05 PM
|
|
|
